The researchers found only one in five of the treatments was of benefit.
But the Tories said the fund gave patients "precious extra time".
Nearly 100,000 patients received drugs under the scheme. It was run separately to the normal NHS process for assessing the effectiveness and affordability of new drugs, which is administered by a body called NICE. BBC News
See also:
- Do patient access schemes for high-cost cancer drugs deliver value to society?—lessons from the NHS Cancer Drugs Fund (open access) Annals of Oncology
- Are NHS patients getting the best medicines? BBC News
- £1.3bn NHS cancer drug fund 'doesn't help patient' The Daily Mail
No comments:
Post a Comment